Amgen, Inc. ( NASDAQ:AMGN ) has succeeded yet again in its aggressive efforts aimed at preventing Sandoz, the generics drug unit of Novartis AG (ADR) ( NYSE:NVS ), from launching a biosimilar version of its blockbuster cancer drug Neupogen in the ... Bidness Etc, 2 weeks ago
Here's Why Amgen, Inc. (AMGN) Surged In Friday's Trading - Bidness Etc, 2 weeks ago
Americans are running out of places to rent (SPSIHO) - Mr Top Step, 2 weeks ago
1 images for "sandoz inc"
Momenta Pharmaceuticals, Inc., a biotechnology company, has announced that the FDA has granted marketing approval for Sandoz's abbreviated new drug application, or ANDA, for Glatopa 20mg/mL, a once daily, generic equivalent of COPAXONE 20mg, ...Individual.com, 1 month ago FDA Approves Generic Multiple-Sclerosis Drug by Novartis's Sandoz and Momenta -- Update 4 Traders, 1 month ago
More from: Nasdaq, Nasdaq...and 3 other sources
After an unsuccessful attempt to obtain a preliminary injunction against Sandoz Inc.'s (Sandoz) Zarxio®  in the District Court for the Northern District of California,  Amgen Inc. (Amgen) has prevailed before the Federal Circuit in excluding ...JD Supra, 2 weeks ago US judge rejects Amgen injunction bid against Novartis Sandoz unit Economic Times, 2 months ago
The sale of Sandoz's biosimilar version of Amgen Inc,'s drug Neupogen is on hold. Source: Healthcare Packaging: News, trends and analysis of pharmaceuticals, biologics, medical devices, and nutraceuticalsConverter News, 2 weeks ago Global Biosimilar Market Outlook 2020 Town Hall, 4 weeks ago Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth TickerTech.com, 4 days ago Zarxio®, First BPCIA Approved Biosimilar, Added to Purple Book JD Supra, 1 month ago
Unfortunately, the Supreme Court's Teva decision has left us some open questions In Teva Pharm. U.S.A. Inc. v. Sandoz, Inc., the Supreme Court ruled that the Court of Appeals for the Federal Circuit should review a district court's factual ...Inside Counsel, 2 weeks ago Spectrum Pharms., Inc. v. Sandoz Inc. JD Supra, 3 weeks ago Teva Pharms USA, Inc. v. Sandoz, Inc. JD Supra, 1 month ago IP Newsflash - May 2015 #2 JD Supra, 2 weeks ago
Steptoe's Federal Circuit win for Sandoz Inc. in a patent dispute over a children's asthma drug was covered by Law360 in an article titled "Fed. Circ. Affirms Invalidity of AstraZeneca Inhaler Patent." The article discusses a May 7 decision from the ...Noodls, 2 weeks ago Federal Circuit Keeps Sandoz Biosimilar Off The Market For Now National Law Review, 2 weeks ago
Last Friday the Patent Trial and Appeal Board (PTAB) denied four Sandoz Inc. petitions for instituting inter partes review (IPR) of U.S. 8,455,524 (IPR2015-00005), U.S. 7,612,102 (IPR2015-00006), U.S. 7,659,290 (IPR2015-00007), and U.S. 7,659,291 B2 ...National Law Review, 3 weeks ago
Momenta Pharmaceuticals Inc. (MNTA: Quote) has offered to sell 7.25 million shares of its common stock to the public at a price of $19.00 each. The underwriters have an option to purchase up to an additional 1.08 million shares of the company's ...RTTNews.com, 1 week ago Anacor Pharmaceuticals Reports First Quarter 2015 Financial Results Pharmacy Choice, 1 week ago InSite Vision, Inc. (INSV: OTCQB) | InSite Vision Reports First Quarter 2015 Financial Results OTC Markets, 2 weeks ago MOMENTA PHARMACEUTICALS INC - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Pharmacy Choice, 3 weeks ago
May. 18, 2015 9:38 AM ET | About: Spectrum Pharmaceuticals, Inc. (SPPI) by: Summary We continue to find meaningful downside to SPPI from its current stock price. SPPI's assets do not fit our view of the criteria of recent M&A deals in the ...Seeking Alpha, 1 week ago
ceuticals, Inc (EPRS) by: Jason Napodano, CFA Subscribers to SA PRO had an early look at this article. Learn more about PRO » Summary In March 2015, the U.S. FDA approved the first biosimilar product in the U.S. in Novartis' Zarxio, a ...Seeking Alpha, 1 week ago
on your WebpageAdd Widget >Get your members hooked!